PAUCIULLO, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 591
EU - Europa 178
AS - Asia 176
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 956
Nazione #
US - Stati Uniti d'America 563
SG - Singapore 90
CN - Cina 81
IT - Italia 46
UA - Ucraina 40
FI - Finlandia 33
CA - Canada 28
DE - Germania 21
IE - Irlanda 10
NL - Olanda 10
CI - Costa d'Avorio 9
GB - Regno Unito 9
SE - Svezia 9
IR - Iran 5
EU - Europa 2
Totale 956
Città #
Chandler 94
Singapore 75
Jacksonville 56
Santa Clara 39
Millbury 37
Princeton 33
Ottawa 26
Nanjing 18
Beijing 14
Boardman 14
Boston 14
Wilmington 14
Amsterdam 10
Woodbridge 10
Ashburn 9
Nanchang 7
Augusta 6
Hebei 6
Shenyang 6
Jiaxing 5
Kunming 5
Naples 5
Kronberg 4
Orange 4
Tianjin 4
Falls Church 3
San Mateo 3
Ardabil 2
Castellammare Di Stabia 2
Jinan 2
Leawood 2
Norwalk 2
Redmond 2
Salerno 2
The Dalles 2
Toronto 2
Changsha 1
Cutrofiano 1
Fisciano 1
Frattamaggiore 1
Fremont 1
Genoa 1
Hangzhou 1
Hanover 1
Munich 1
Napoli 1
Portici 1
Prato 1
Quartu Sant'elena 1
Rome 1
Sandston 1
Shanghai 1
Simi Valley 1
Springfield 1
Totale 557
Nome #
Apo B, Small-dense LDL and carotid atherosclerosis in menopausal women 50
Effect of statins on LDL particle size in patients with familial combined hyperlipidemia: a comparison between atorvastatin and pravastatin. 48
Association between small dense LDL particles and early atherosclerosis in a sample of middle-aged women. Findings from Progetto Atena 40
Familial Combined hyperlipidemia and IMT 38
More inflammation in Familial Hypercholesterolemia than in Familial Combined Hyperlipidemia. 38
Association between retinopathy and impaired peripheral arterial circulation in insulin dependent diabetic patients. 37
Familial combined hyperlipoproteinemia: experts panel position on diagnostic criteria for clinical practice. Committee of experts of the Atherosclerosis and Dysmetabolic Disorders Study Group. 35
Screening for Familial Combined Hyperlipidemia criteria in a cohort of Mediterranean women: findings from Progetto ATENA 35
Left ventricular geometry and arterial function in hypercholesterolemia 34
Effects of weight modification on hs-crp in a cohort of mediterranean women: findings from progetto atena. 34
Inflammatory markers in Familial Combined Hyperlipidemia 33
Effect of dietary versus pharmacological correction of hypertriglyceridemia on red blood cell membrane sodium/lithium countertransport activity. 33
Increased carotid artery intima-media thickness is associated with a novel mutation of low-density lipoprotein receptor independently of major cardiovascular risk factors. 31
Biochemical Screening for Familial Combined Hyperlipidemia 31
Impaired endothelium-dependent vascular reactivity in patients with familial combined hyperlipidaemia. 30
LE DISLIPIDEMIE SU BASI GENETICHE 30
Early carotid atherosclerosis in obesity and overweight is independent of hs-CRP in a cohort of mediterranean women: findings from Progetto Atena 30
Lipoprotein transport and metabolism: a brief update 29
Efficacy and safety of a combination of fluvastatin and bezafibrate in patients with mixed hyperlipidaemia (FACT study). 29
Non-invasive vascular detection of early signs of atherosclerosis in hypercholesterolemic children: why and how. 28
LDL receptor cDNA sequence analysis in familial hypercholesterolemia patients: 5 novel mutations with high prevalence in families originating from southern Italy. 28
Le dislipidemie familiari: nuovi approcci per una vecchia sfida 28
Associate Editor 28
Tumor Necrosis Factor-α is a marker of Familial Conbined Hyperlipidemia, independently of metabolic sindrome 28
Regulatory networks and regulatory sequences in familial combined hyperlipidemia patients. 27
Gli studi di placca 26
LDL AFERESI E PLASMA EXCHANGE, INDICAZIONI E RISULTATI CLINICI 25
Associate Editor 25
Diabetes mellitus and localization of obliterating arterial disease of the lower limbs. 21
Tumor necrosis factor-α is a marker of familial combined hyperlipidemia, independently of metabolic syndrome 20
MARCATORI DELL'INFIAMMAZIONE NELLE DISLIPOPROTEINEMIE FAMILIARI 18
Il paziente a rischio cardiovascolare intermedio: focus sulla Atorvastatina 16
Very low density lipoprotein. Qualitative abnormalities in patients with premature coronary heart disease and in patients with insulin dependent diabetes. 13
Totale 996
Categoria #
all - tutte 4.884
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.884


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202074 0 0 0 0 22 0 0 0 0 6 18 28
2020/2021116 1 12 11 8 9 30 8 0 9 1 27 0
2021/2022162 4 0 0 0 0 0 0 2 11 19 52 74
2022/2023219 33 14 2 8 40 29 0 27 43 11 10 2
2023/2024129 8 26 15 7 3 7 2 13 1 0 24 23
2024/2025140 39 66 1 6 28 0 0 0 0 0 0 0
Totale 996